Exagen Inc. Common Stock (XGN) is a publicly traded Healthcare sector company. As of July 21, 2026, XGN trades at $4.90 with a market cap of $113.07M and a P/E ratio of -5.38. XGN moved +3.53% today. Year to date, XGN is -20.07%; over the trailing twelve months it is -30.27%. Its 52-week range spans $2.59 to $12.23. Analyst consensus is strong buy with an average price target of $8.00. Rallies surfaces XGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for XGN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $4.90 |
| Market Cap | $113.07M |
| P/E Ratio | -5.38 |
| EPS | $-0.89 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.23 |
| 52-Week Low | $2.59 |
| Volume | 219.19K |
| Avg Volume | 0 |
| Revenue (TTM) | $68.38M |
| Net Income | $-20.17M |
| Gross Margin | 58.32% |
4 analysts cover XGN: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.00.